Testicular Cancer clinical trials in Florida

8 actively recruiting testicular cancer trials at 21 sites across Florida.

Data from ClinicalTrials.gov · last refreshed 2026-04-20

Phase 3 Recruiting Network

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it dev…

Sponsor: Children's Oncology Group

NCT ID: NCT03067181

Sites in Florida:

Broward Health Medical Center — Fort Lauderdale, Florida
Golisano Children's Hospital of Southwest Florida — Fort Myers, Florida
UF Health Cancer Institute - Gainesville — Gainesville, Florida
Memorial Regional Hospital/Joe DiMaggio Children's Hospital — Hollywood, Florida
Nemours Children's Clinic-Jacksonville — Jacksonville, Florida

View on ClinicalTrials.gov →

Phase 3 Recruiting Network

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy and immunotherapy (chemo-immunotherapy) for patients with High-Risk B-cell Acute Lymphoblastic Leukemia (B-ALL) improves outcomes. Inotuzumab o…

Sponsor: Children's Oncology Group

NCT ID: NCT03959085

Sites in Florida:

Broward Health Medical Center — Fort Lauderdale, Florida
Golisano Children's Hospital of Southwest Florida — Fort Myers, Florida
UF Health Cancer Institute - Gainesville — Gainesville, Florida
Memorial Regional Hospital/Joe DiMaggio Children's Hospital — Hollywood, Florida
Nemours Children's Clinic-Jacksonville — Jacksonville, Florida

View on ClinicalTrials.gov →

Phase 2 Recruiting NIH

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

This phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that has spread from where it first started (primary site) to other places in the…

Sponsor: National Cancer Institute (NCI)

NCT ID: NCT03866382

Sites in Florida:

Mount Sinai Comprehensive Cancer Center at Aventura — Aventura, Florida
Holy Cross Hospital — Fort Lauderdale, Florida
Mount Sinai Medical Center — Miami Beach, Florida
Orlando Health Cancer Institute — Orlando, Florida

View on ClinicalTrials.gov →

Phase 2 Recruiting Academic/Other

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

This clinical trial studies the effect of cancer directed therapy given at-home versus in the clinic for patients with cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (adv…

Sponsor: Mayo Clinic

NCT ID: NCT05969860

Sites in Florida:

Mayo Clinic in Florida — Jacksonville, Florida

View on ClinicalTrials.gov →

Phase 1 Recruiting Industry

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

The primary purpose of this study is to determine whether the investigational drug XmAb541 is safe and well tolerated, and to determine an optimal and safe dose(s) for further study. The study will also evaluate the effect of XmAb541 on tu…

Sponsor: Xencor, Inc.

NCT ID: NCT06276491

Sites in Florida:

Moffitt Cancer Center — Tampa, Florida

View on ClinicalTrials.gov →

Recruiting Industry

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool, powered by a virtual tumor boards (VTB) program, and its clinic…

Sponsor: Massive Bio, Inc.

NCT ID: NCT03452774

Sites in Florida:

Massive Bio SYNERGY-AI site — Jacksonville, Florida
Massive Bio SYNERGY-AI site — Miami, Florida
Massive Bio SYNERGY-AI site — Tampa, Florida

View on ClinicalTrials.gov →

Recruiting Academic/Other

Integrated Cancer Repository for Cancer Research

The iCaRe2 is a multi-institutional resource created and maintained by the Fred \& Pamela Buffett Cancer Center to collect and manage standardized, multi-dimensional, longitudinal data and biospecimens on consented adult cancer patients, h…

Sponsor: University of Nebraska

NCT ID: NCT02012699

Sites in Florida:

Florida Hospital Memorial Medical Center — Daytona Beach, Florida
Florida Hospital DeLand — DeLand, Florida
Florida Hospital FISH — Orange City, Florida
Florida Hospital Flagler — Palm Coast, Florida
Tallahassee Memorial Hospital — Tallahassee, Florida

View on ClinicalTrials.gov →

Recruiting Industry

DESTINY-PANTUMOUR04

This study will evaluate the effectiveness of T-DXd in patients with HER2-positive (IHC 3+) locally advanced, unresectable, or metastatic solid tumors who have received prior systemic treatment for metastatic or advanced disease and have n…

Sponsor: AstraZeneca

NCT ID: NCT07124000

Sites in Florida:

Research Site — Coral Springs, Florida
Research Site — Fort Myers, Florida
Research Site — Palm Harbor, Florida

View on ClinicalTrials.gov →

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-04-20